Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Oner Sanli"'
Autor:
Yuval Freifeld, Hans J. Hammers, Aditya Bagrodia, Laura Maria Krabbe, Yair Lotan, Vitaly Margulis, Oner Sanli, Nirmish Singla, Timothy Clinton, Ryan Hutchinson, Raquibul Hannan, James Brugarolas, Justin T. Matulay, Solomon L. Woldu
Publikováno v:
Clinical Genitourinary Cancer. 16:e1221-e1235
Background The optimal timing of targeted therapy (TT) initiation for metastatic renal-cell carcinoma (mRCC) is not clear. We used a nationwide cancer registry to determine clinical and social factors associated with delayed TT and to evaluate the as
Publikováno v:
Clinical Nuclear Medicine. 47:e45-e46
68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a well-established imaging modality in patients with prostate cancer; however, PSMA expression is also reported in the tumor-associated neovasculature, including but not limited to hepatocellul
Publikováno v:
Diagnosis and Surgical Management of Renal Tumors ISBN: 9783319923086
Metastatic renal cell carcinoma (mRCC) has historically been associated with limited treatment options and poor prognosis. Based on data from two prospective trials in the cytokine immunotherapy era, cytoreductive nephrectomy (CN) was adopted as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b35a87e6d2942cc0ebb4b5b3a6389eb
https://doi.org/10.1007/978-3-319-92309-3_17
https://doi.org/10.1007/978-3-319-92309-3_17
Autor:
Oner Sanli, Ömer Acar
Publikováno v:
Surgery Research and Practice
Surgery Research and Practice, Vol 2016 (2016)
Surgery Research and Practice, Vol 2016 (2016)
Surgical resection either in the form of radical nephrectomy or in the form of partial nephrectomy represents the mainstay options in the treatment of kidney cancer. In most instances, resecting the tumor bearing kidney or the tumor itself provides d
Autor:
Andres Matoso, Oner Sanli, Diana Taheri, Yasemin Ozluk, Sohail Balasubramanian, George J. Netto, Evgeny Yakirevich, Jeffrey S. Ross, Neslihan Kayisoglu Berker, Siraj M. Ali
Publikováno v:
Human Pathology. 46:1951-1955
Renal cell carcinoma (RCC) linked to germline mutation of succinate dehydrogenase subunits A, B, C, and D (SDHA, SDHB, SDHC, and SDHD, respectively) has been recently included as a provisional entity in the 2013 International Society of Urological Pa
Autor:
Yair Lotan, Oner Sanli, Hans J. Hammers, Vitaly Margulis, James Brugarolas, Solomon L. Woldu, Yuval Freifeld, Raquibul Hannan, Justin T. Matulay, Timothy Clinton, Nirmish Singla, Ryan Hutchinson, Laura-Maria Krabbe, Aditya Bagrodia
Publikováno v:
Journal of Urology. 199
Autor:
Samed Verep, Selcuk Erdem, Tzevat Tefik, Oner Sanli, Yasar Pazir, Faruk Özcan, Murat Tunc, Ismet Nane
Publikováno v:
Journal of Urology. 199
Autor:
Dilek Telci, Halim Issever, Tzevat Tefik, Selcuk Erdem, Gulcin Yegen, Ibrahim Yildiz, Oner Sanli, Isin Kilicaslan
Publikováno v:
World Journal of Urology. 33:1553-1560
The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues. A total of 33 metastatic RCC(mRCC) and 33 non-metastati
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 32:1031-1040
Background and objective: The relationship between renal cell carcinoma (RCC) and coagulation/fibrinolysis system has been described in several studies. The aim of this study was to investigate the role of 4 different coagulation/fibrinolysis factors
Publikováno v:
Journal of Minimal Access Surgery, Vol 9, Iss 4, Pp 168-172 (2013)
Journal of Minimal Access Surgery
Journal of Minimal Access Surgery
Background: To report our initial experiences using a combined retroperitoneoscopic and transperitoneal laparoscopic technique for the management of renal cell carcinoma with level I tumor thrombi. Materials and Methods: Two patients underwent this t